DATALEND TRENDING - FEBRUARY 06, 2014


 

$TWTR

Twitter

$JCP

JC Penney

$MR

Mindray Medical

Utilization     94.54% 97.25% 90.16%
Short Interest 5.87% 39.67% 28.64%
Days to Cover 1.64 3.45 22.19
Fees to Borrow*
Down Up Down
*Since Previous Trading Day


SECURITIES LENDING TOP 10 EARNING EQUITIES - FEBRUARY 07, 2014


US

Utilization

1     MYRIAD GENETICS 94.97%
2     INTEROIL 98.76%
3     MINDRAY MEDICAL INTL ADR CL A 90.16%
4     ARENA PHARMACEUTICALS 95.71%
5     WEIGHT WATCHERS INTERNATIONAL 97.39%
6     SANDRIDGE ENERGY 96.00%
7     TWITTER 94.54%
8     HALCON RESOURCES 97.50%
9     IPG PHOTONICS 86.64%
10   OPKO HEALTH 97.83%

  • Myriad Genetics ($MYGN) fees to borrow were declining from the January 23 peak but have been climbing again in February. Utilization has held steady around 95% for the past two months.
  • Interoil ($IOC) fees to borrow have been trending steadily higher since January 22, now reaching nearly four times the rates seen then. Utilization was nearly maxed out by the end of January but is down just a touch since then.
  • Mindray Medical ($MR) fees to borrow and utilization have been fairly stable at these levels since the start of the year. A research firm has claimed the medical equipment manufacturer has committed accounting fraud (Securities Lending Times).

UK

Utilization

1     BLINKX 68.35%
2     GULF KEYSTONE PETROLEUM 88.48%
3     TALVIVAARA MINING 87.67%
4     APR ENERGY 58.78%
5     STOBART GROUP 72.37%
6     KAZAKHMYS 71.50%
7     CARPETRIGHT 47.37%
8     NANOCO GROUP 85.02%
9     DAISY GROUP 51.70%
10   TESCO 8.05%

  • Blinkx ($BLNX.LN) fees to borrow are trending even higher. At this utilization, nearly a third of its securities lending inventory is available to be borrowed. A Harvard professor recently published a blog post claiming the London-based video search company inflated traffic numbers, knocking down the firm’s stock price (Bloomberg).
  • Gulf Keystone ($GKP.LN) fees to borrow have been up and down a touch over the past two months, but never by much. Utilization has been pushing 90% for months.
  • Long-term volume-weighted average fees to borrow buckets for the U.K.’s third top earner, Talvivaara Mining ($TALV.LN), show a continued, gradual rise. Utilization has been steady at this level for about two months now.



Europe

Utilization

1     BANCA MONTE DEI PASCHI DI SIENA (IT) 86.99%
2     PEUGEOT (FR) 82.51%
3     THROMBOGENICS 89.65%
4     OUTOTEC (FI) 79.20%
5     UNIBAIL RODAMCO REIT (FR) 6.38%
6     ACERINOX (ES) 68.83%
7     GEMALTO (FR) 85.33%
8     MELIA HOTELS INTERNATIONAL (ES) 84.54%
9     OUTOKUMPU (FI) 81.11%
10   NORWEGIAN AIR SHUTTLE (NO) 84.95%

  • Banca Monte Dei Paschi di Siena ($BMPS.IM) fees to borrow have held steady since recovering from the dip in early January. Utilization has been rising again since then too.
  • Utilization of Peugeot ($UG.FP) stock has been steadily rising since early October. Fees to borrow dipped somewhat in January but have rose again to the highs seen in late December.
  • ThromboGenics ($THR.BB) fees to borrow continue to trend steadily higher in contrast to the stock price decline. Utilization is lower than the levels seen in late summer but is climbing back up—by 5% in the last few weeks alone.



Far East/Australia Pacific

Utilization

1     GUNGHO ONLINE (JP) 94.80%
2     CELLTRION (KR) 77.25%
3     BYD COMPANY H (HK) 78.08%
4     HANERGY SOLAR (HK) 82.20%
5     GREE (JP) 90.52%
6     ANA HOLDINGS (JP) 89.33%
7     SINGAPORE PRESS HOLDINGS (SG)  80.03%
8     OLAM INTERNATIONAL (SG) 72.13%
9     HUISHAN DAIRY 73.41%
10   MONADELPHOUS GROUP (AU) 74.05%

  • GungHo Online ($3765.JP) fees to borrow showed signs of slight declines in January but have reached recent highs again this week. Utilization continues to hold steady at these levels.
  • Celltrion ($068270.KS) fees to borrow continue to trend steadily higher since the summer decline reversed. Utilization has climbed to new highs.
  • BYD Company ($1211.HK) fees to borrow have been trending higher for more than a month, while utilization has inched upward. Bloomberg reported last month that the Chinese automaker said it would bring its cars to the U.S. by next year.

 

This is just a snapshot of the rich data and functionalities provided by DataLend. Click here for more information about DataLend's key features.



THE INFORMATION CONTAINED HEREIN IS PROPRIETARY TO EQUILEND; MAY NOT BE COPIED OR DISTRIBUTED WITHOUT THE EXPRESS CONSENT OF EQUILEND; SHALL NOT CONSTITUTE INVESTMENT ADVICE BY EQUILEND, OR ANY REPRESENTATIVE THEREOF; IS NOT WARRANTED TO BE ACCURATE, COMPLETE OR TIMELY; IS PROVIDED FOR INFORMATIONAL PURPOSES ONLY; IS NOT INTENDED FOR TRADING PURPOSES; AND SHOULD NOT BE CONSTRUED AS EQUILEND MAKING FORECASTS, PROJECTING RETURNS OR RECOMMENDING ANY PARTICULAR COURSE OF ACTION. NEITHER EQUILEND NOR ANY REPRESENTATIVE THEREOF SHALL BE AN ADVISOR OR A FIDUCIARY OF A VISITOR TO THIS WEBSITE. EQUILEND IS NOT RESPONSIBLE OR LIABLE IN ANY WAY TO THE READER OR VISITOR, OR TO ANY PERSON, FIRM OR CORPORATION FOR ANY DAMAGES OR LOSSES ARISING FROM ANY USE OF THE INFORMATION CONTAINED HEREIN. IN CONSIDERING THE INFORMATION CONTAINED HEREIN, A VISITOR TO THIS WEBSITE DOES SO SOLELY IN RELIANCE ON THE VISITOR’S OWN JUDGMENT. PAST PERFORMANCE IS NO GUARANTEE OF FUTURE PERFORMANCE.

DATALEND ALERTS

Sign up for weekly DataLend Top 10 email alerts



DATA ARCHIVE

March 09, 2015

March 2, 2015

February 27, 2015

January 26, 2015

November 19, 2014

November 12, 2014

November 5, 2014

October 22, 2014

October 15, 2014

October 8, 2014

September 19, 2014

September 5, 2014

August 28, 2014

August 21, 2014

July 24, 2014

June 26, 2014

June 19, 2014

June 12, 2014

June 5, 2014

May 29, 2014

May 22, 2014

May 16, 2014

May 8, 2014

May 1, 2014

April 25, 2014

April 11, 2014

April 4, 2014

March 20, 2014

March 13, 2014

March 7, 2014

February 27, 2014

February 20, 2014

February 7, 2014